Inicio01P • FRA
add
Medpace
Cierre anterior
316,10 €
Intervalo diario
315,40 € - 327,90 €
Intervalo anual
213,00 € - 418,70 €
Cap. bursátil
11,05 mil M USD
Volumen medio
8,00
Relación precio-beneficio
-
Rentabilidad por dividendo
-
Bolsa de valores principal
NASDAQ
En las noticias
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
(USD) | jun 2024info | Cambio interanual |
---|---|---|
Ingresos | 528,10 M | 14,59 % |
Gastos operativos | 251,41 M | 12,26 % |
Ingresos netos | 88,35 M | 44,68 % |
Margen de beneficio neto | 16,73 | 26,26 % |
Beneficios por acción | 2,76 | 41,81 % |
EBITDA | 112,38 M | 32,35 % |
Tipo impositivo efectivo | 20,03 % | — |
Balance general
Activos totales
Responsabilidades totales
(USD) | jun 2024info | Cambio interanual |
---|---|---|
Efectivo y a corto plazo | 510,89 M | 1.205,37 % |
Activos totales | 1920,05 M | 36,47 % |
Responsabilidades totales | 1156,45 M | 13,84 % |
Patrimonio total | 763,60 M | — |
Acciones en circulación | 30,93 M | — |
Precio-valor contable | 12,80 | — |
Rentabilidad económica | 14,15 % | — |
Retorno sobre capital | 30,09 % | — |
Flujo de caja
Variación neta del flujo de caja
(USD) | jun 2024info | Cambio interanual |
---|---|---|
Ingresos netos | 88,35 M | 44,68 % |
Efectivo de operaciones | 116,40 M | 41,06 % |
Efectivo de inversión | -12,79 M | -51,06 % |
Efectivo de financiación | 666,00 mil | 100,81 % |
Variación neta del flujo de caja | 103,88 M | 1.434,58 % |
Flujo de caja libre | 76,42 M | 23,59 % |
Información sobre la empresa
Medpace Holdings, Inc. is a global clinical research organization based in Cincinnati, Ohio, employing approximately 5,400 people. Medpace's mission statement is "to accelerate the global development of safe and effective medical therapeutics" through its high science and disciplined operating approach that leverages local, regulatory, and deep therapeutic expertise across all major areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Operating under a full-service model, Medpace provides a therapeutically focused, integrated, global approach to clinical development. The company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
The company started trading stock as a public firm in 2016. Wikipedia
Director ejecutivo
Fundación
1992
Sitio web
Empleados
5.800